A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder

Hunter, Myra; Ussher, Jane M.; Browne, Susannah; Cariss, Margaret; Jelley, R. Blake; Katz, Maurice

doi:10.3109/01674820209074672

Cited by 108 publications

(68 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Tedavileri kombine etmenin ek bir yararı görülmemiş ve tedavi gruplarında etkinlikte bir değişiklik olmadığı belirlenmiştir. 21 …”

Section: Bi̇li̇şsel Davranişsal Tedavi̇unclassified

Evıdence Based Approaches and Nursery Care in Dıagnosıs and Therapy of Premenstrual Syndrome

Beji¹

2015

BSBD

View full text Add to dashboard Cite

ÖZETPremenstrual sendrom, menstruel siklusun luteal fazında ortaya çıkan, menstruasyonun başlamasıyla azalan yâda kaybolan, altta yatan bir psikiyatrik hastalık olmaksızın, rahatsızlık veren fiziksel, davranışsal ve psikolojik semptomlarla kendini gösteren bir durumdur. Premenstruel sendrom kadınları etkileyen bir problem olup, bu sendromun etyolojisi halen kesin olarak bilinmemektedir. Bu sendromun tanı ve tedavi aşamasında sağlık profesyonelleri anahtar bir role sahiptir. Sağlık profesyonelleri kadınların objektif ve subjektif verileri değerlendirerek ayrıntılı bir anamnez almalıdır. Kadınların yaşam kalitesini arttırmak için premenstrual sendrom tedavisi ile ilgili danışmanlık yapılmalıdır. Bunun için sağlık profesyonelleri PMS'nin farkında olmalı ve tedavi yaklaşımı konusunda bilgi sahibi olmalıdır. Bu derlemede premenstruel sendromun tanımı, çeşitleri, etiyolojisi, tanı ve tedavi yaklaşımları ve sağlık profesyonellerine düşen görevler tartışılacaktır.Anahtar Kelimeler: Premenstrual sendrom, Hemşirelik Yaklaşımı, Kanıta Dayalı Uygulamalar. SUMMARYPremenstrual Syndrome is a condition that appears in the luteal phase of menstrual cycles and decreases or fades away with menstruation. This condition might manifest itself through behavioral, psychological and physical symptoms, which are usually discomforting, and has no underlying psychiatric causes. Premenstrual Syndrome is a problem that affects women and its etiology is still not known for certain. In its diagnosis and treatment, the healthcare officials play a fundamental role. The healthcare officials should acquire a detailed anamnesis by assessing the objective and subjective information received from women. There should be consultation services that inform women about its treatment and thus seek to enhance the life quality of women. Therefore, the healthcare officials should be aware of PMS and should be knowledgeable about treatment processes. This review discusses the definition, types, etiology, diagnosis and treatment of Premenstrual Syndrome and the responsibilities of the healthcare officials.

show abstract

“…Tedavileri kombine etmenin ek bir yararı görülmemiş ve tedavi gruplarında etkinlikte bir değişiklik olmadığı belirlenmiştir. 21 …”

Section: Bi̇li̇şsel Davranişsal Tedavi̇unclassified

Evıdence Based Approaches and Nursery Care in Dıagnosıs and Therapy of Premenstrual Syndrome

Beji¹

2015

BSBD

View full text Add to dashboard Cite

show abstract

“…Il gruppo trattato con fluoxetina, tuttavia, ha fatto registrare una più rapida risoluzione dei sintomi, mentre il gruppo trattato con psicoterapia ha manifestato una minor tendenza alla recidiva durante la fase di mantenimento. L'associazione tra fluoxetina e psicoterapia non ha comportato un potenziamento dei risultati [80].…”

Section: A Disturbo Disforico Premestrualeunclassified

Fluoxetina: profilo terapeutico e farmacoeconomico di un prodotto generico

Pepa

Eandi

2003

View full text Add to dashboard Cite

Fluoxetine has been the first antidepressive agent of the class of selective serotonine reuptake inhibitors (SSRI) to be introduced in therapy, back in 1987. The availability of SSRIs has meant a great advance in the treatment of major depression and other neuro-psychiatric pathologies. In this paper we review the scientific and clinical research on fluoxetine that has been published in the last six years, as the prior work has been extensively examined in a review conducted on the tenth anniversary of its introduction on the market. The review focuses on cost minimization strategies that can be conducted following the introduction of low cost generic fluoxetine.

show abstract

“…Ten sessions of cognitive behavioural therapy (CBT) were associated with an even better result in one year of follow up [33]. However, the study needs to be replicated as the size of the sample was small and the rate of abandonment was high.…”

Section: Randomized Clinical Trialsmentioning

confidence: 99%

Estrogen and Transdiagnostics: A Systematic Review

Almeida¹,

Nardi²

2016

J Depress Anxiety

View full text Add to dashboard Cite

perform a systematic review, making reference to the scientific literature on female patients with estrogen fluctuations which individuals influence the occurrence, intensity, expression of different disorders of mood or anxiety (transdiagnostic). SourcesSearches were carried out in the ISI Web of Science and PubMed databases, utilizing the terms "estrogen", "anxiety disorder" and "mood disorder". The search was performed in May and June of 2015, with a temporal restriction of 10 years in both databases. Articles that were reviews or repeated were excluded, as were studies that were not available in English. Study SelectionA total of 1060 references were found, 673 on PubMed and 387 on ISI Web of Science, among which 11 were duplicates and 52 were in languages other than English. Of the remaining 997 references, 118 were excluded by prior review, 114 for having incoherent abstracts, 727 by title and 20 by eligibility, leaving a total of 16 articles to compose this review. The eligibility criteria were the hormone physiological relation with the prevalence of the anxiety and mood disorders. AbstractObjective: To evaluate, through systematic review, whether the role of estrogen influences the onset of disorders in anxiety and depression. Data Sources: The search was performed in two databases, ISI Web of Science and PubMed, using the terms estrogen, anxiety and mood. Study selection:The search produced 1060 references. Those that were repeated or not written in English were excluded. After analysis of the abstracts, 38 were selected to have their texts read, of which 18 were chosen for the execution of this review. Data collection:The PubMed and ISI Web of Science articles were extracted in June 2015. Moreover, the study was also restricted to articles that involved adult patients and were elaborated between 2005 and 2015.Results: There were six case-control observational studies, followed by four randomized clinical trials. The results in smaller quantities in the review were: three retrospective cohort observational studies and three cross-sectional studies, followed by one prospective cohort observational study. A letter to an editor was also included. The result that stood out in the review was the finding that women are twice as likely to suffer from disturbances of anxiety or mood, such as generalized anxiety disorder, panic disorder, post-traumatic stress disorder and bipolar disorder. Conclusion:Some women there is a greater vulnerability to hormonal oscillations of estrogen (in pre-menstrual and postpartum periods and in the pre-menopause) leading to the aforementioned disorders.

show abstract

A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder

Cited by 108 publications

References 17 publications

Evıdence Based Approaches and Nursery Care in Dıagnosıs and Therapy of Premenstrual Syndrome

Evıdence Based Approaches and Nursery Care in Dıagnosıs and Therapy of Premenstrual Syndrome

Fluoxetina: profilo terapeutico e farmacoeconomico di un prodotto generico

Estrogen and Transdiagnostics: A Systematic Review

Contact Info

Product

Resources

About